BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1983210)

  • 1. Molecular genetic aspects of glial tumour evolution.
    James CD; Mikkelsen T; Cavenee WK; Collins VP
    Cancer Surv; 1990; 9(4):631-44. PubMed ID: 1983210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal genomic alterations in glioma malignancy stages.
    James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
    Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the TP53 gene in human gliomas.
    Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
    Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The molecular genetics of gliomas and the outlook for molecular neurosurgery].
    Zozulia IuA; Gridina NIa
    Zh Vopr Neirokhir Im N N Burdenko; 1998; (4):45-51. PubMed ID: 9988893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular biology in cerebral gliomas: recent advances].
    Hoang-Xuan K; Li YJ; Hamelin R; Delattre O
    Rev Neurol (Paris); 1995 Nov; 151(11):608-18. PubMed ID: 8745624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
    Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
    Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The concept of suppressor genes in the molecular biology of central nervous system tumors].
    el-Azouzi M; Black PM
    Neurochirurgie; 1989; 35(4):201-8. PubMed ID: 2575713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biology and gene therapy of glioma].
    Sanson M; Hoang-Xuan K
    Rev Prat; 1996 Feb; 46(4):464-8. PubMed ID: 8729353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.
    Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP
    Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of sequential genetic alterations relevant for breast cancer development.
    Niederacher D; Schnürch HG; An HX; Ellenberger I; Dall P; van Roeyen CR; Küppers V; Beckmann MW
    Eur J Cancer Prev; 1996 Dec; 5(6):497-503. PubMed ID: 9061283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial glioma in two siblings.
    Uzal D; Ozyar E; Tükül A; Genç M; Söylemezoğlu F; Atahan IL; Onol B
    Radiat Med; 1996; 14(1):43-7. PubMed ID: 8725378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focusing on the molecular genetic analysis of the glioma].
    Jiang T; Lin Y
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2307-8. PubMed ID: 19087687
    [No Abstract]   [Full Text] [Related]  

  • 15. The p53 gene and its role in human brain tumors.
    Bögler O; Huang HJ; Kleihues P; Cavenee WK
    Glia; 1995 Nov; 15(3):308-27. PubMed ID: 8586466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant gliomas. Oncogenic considerations].
    Pérez-Ortiz L; Zaldívar-Vaillant T; Tamayo-Suárez JD
    Rev Neurol; 2000 Jul 1-15; 31(1):49-52. PubMed ID: 10948584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
    J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenes and anti-oncogenes in human central nervous system tumors.
    Batra SK; Rasheed BK; Bigner SH; Bigner DD
    Lab Invest; 1994 Nov; 71(5):621-37. PubMed ID: 7967518
    [No Abstract]   [Full Text] [Related]  

  • 19. Applications of mouse glioma models in preclinical trials.
    Hu X; Holland EC
    Mutat Res; 2005 Aug; 576(1-2):54-65. PubMed ID: 16011838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A changing paradigm of glioma biology.
    Shapiro WR; Shapiro JR
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1171-91. PubMed ID: 17113458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.